that led to FDA approval, patient & lobar selection criteria, valve/deployment catheter features, detailed description of procedure, discussing the Chartis Pulmonary Assessment System and StratX report, management of complications and finally discussing next steps in protocolizing post-EBV placement care....
First in Human Experience of the Performance of the New 5.5-LP Size Zephyr Endobronchial Valve. 首先在人类经验的性能新的 5.5-LP 尺寸的 Zephyr 支气管内瓣膜。影响因子:2.30DOI:10.1159/000504182作者列表:"Klooster K","van Dijk M","Koster TD","Slebos DJ...
Patients were included if eligible for valve treatment with a local anatomy suitable to place at least one 5.5-LP EBV. Feasibility of placement of the 5.5-LP EBV was reported. Safety, CT parameters, pulmonary function tests, and St. George's Respiratory Questionnaire (SGRQ) were assessed at ...